Lite Strategy Don Raise $100M for Litecoin Treasury Strategy
Lite Strategy, Inc. (NASDAQ: LITS) don raise $100 million through one private placement for July 2025 to support their new Litecoin Treasury Strategy. The money help dem buy 929,548 LTC tokens, making LITS the first US-listed company wey hold Litecoin as their main reserve. Under the Litecoin Treasury Strategy, Lite Strategy change name from MEI Pharma, update their ticker to LITS and join hand with GSR to handle governance and execution. The company put Litecoin founder Charlie Lee and GSR’s Joshua Riezman for their board to oversee the Litecoin reserves. To make use of their near million LTC holding, Lite Strategy announce $25 million share repurchase program, they dey move from accumulation to active capital market operations. Up till September 30, 2025, the company report $12.21 million working capital and zero debt. Them still dey check their remaining pharmaceutical assets, like preclinical research for voruciclib and licensing opportunities for zandelisib. The Litecoin Treasury Strategy want increase shareholder value by giving direct institutional exposure to Litecoin and use market-driven initiatives.
Bullish
Lite Strategy wen acquire 929,548 LTC tokens plus dem establish Litecoin Treasury Strategy show say institutional demand strong, reduce di tokens wey dey circulate and boost market confidence. Di $100M capital wey dem raise plus new board appointments, wey include Litecoin founder Charlie Lee, make dem credible wella and fit attract more institutional investors, wey fit push price go up inside di long term. Di $25M share repurchase program show say dem serious to increase value, e support better momentum for Litecoin both short term and long term.